Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Myeloma: Isa-KRd Induction Shows High MRD Responses
RIO DE JANEIRO — A quadruplet induction regimen of isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in the treatment of newly diagnosed multiple myeloma (MM) shows a notably high response, with a favorable safety profile, according to the first findings of…
English